Patent Assignment
Reel/Frame 050180/0326
Change of Name
Recorded: 2019-08-27
Pages: 3
Assignor
ZENITH EPIGENETICS CORP.
Executed: 2016-08-01
Assignee
ZENITH CAPITAL CORP.
300,4820 RICHARD ROAD SW, CALGARY, ALBERTA, T3E 6L1, CANADA
Covered Property
(1)
Novel Quinazolinones as Bromodomain Inhibitors
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 27, 2019
From: QUINN, JOHN FREDERICK; KHLEBNIKOV, VLADIMIR
To: RVX THERAPEUTICS INC.
Reel/Frame 050180/0219 →
General Conveyance and Assumption Agreement
Aug 27, 2019
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 050180/0309 →
Assignment of Assignor's Interest
Aug 27, 2019
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 050180/0339 →